These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8793111)

  • 21. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP; Jackson DM; Wallsten C; Waszczak BL
    J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N; Friedman E
    Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants.
    Schmeer C; Obregón F; Urbina M; Lima L
    Neurochem Res; 2001 Mar; 26(3):213-23. PubMed ID: 11495544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of novel 5-HT1A receptor antagonists on measures of post-synaptic 5-HT1A receptor activation in vivo.
    Thielen RJ; Frazer A
    Life Sci; 1995; 56(7):PL163-8. PubMed ID: 7869825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT1A receptor activation: short-term effects on the mRNA expression of the 5-HT1A receptor and galanin in the raphe nuclei.
    Razani H; Hedlund PB; Hansson AC; Fuxe K; Ogren SO
    Neuroreport; 1997 Nov; 8(16):3565-70. PubMed ID: 9427327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin 5-HT1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance.
    Meller E; Chalfin M; Bohmaker K
    Pharmacol Biochem Behav; 1992 Oct; 43(2):405-11. PubMed ID: 1359573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats.
    Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
    Eur J Pharmacol; 1998 Sep; 356(2-3):167-78. PubMed ID: 9774246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J; Lakoski JM
    Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Ni YG; Camacho N; Miledi R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW; Mefford IN; Smith CC; Gold PW; Sternberg EM
    J Neurochem; 1992 Sep; 59(3):1062-70. PubMed ID: 1379629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of three acute stressors on the serotonin 5-HT1A receptor system in rat brain.
    Raghupathi RK; McGonigle P
    Neuroendocrinology; 1997 Apr; 65(4):246-58. PubMed ID: 9142996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
    Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain.
    Kung MP; Zhuang ZP; Frederick D; Kung HF
    Synapse; 1994 Dec; 18(4):359-66. PubMed ID: 7886629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors.
    Thielen RJ; Fangon NB; Frazer A
    J Pharmacol Exp Ther; 1996 May; 277(2):661-70. PubMed ID: 8627543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
    J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.